Montpellier, Jan 10th 2011 – The French-based company OriBase Pharma has moved into new Headquarters in Biopôle, Montpellier, located in Parc Euromédecine. These facilities provide OriBase Pharma with a new and spacious medicinal chemistry laboratory, complying with EU requirements for hygiene and safety. Moreover, this move allows OriBase Pharma to consolidate its multi-disciplinary teams of researchers on the same site.
«Our new facilities in Biopôle, Montpellier, correspond to our need for increasing our activities, especially within medicinal chemistry, and in ensuring the possibility for further expansion of our team», says Aziz Yasri, CEO at OriBase Pharma.
The new company information of OriBase Pharma:
1682, Rue de la Valsière
Parc Euromédecine, Cap Gamma
34090 Montpellier - France
Phone: +33 (0)4 67 727 670
Fax: +33 (0)4 67 727 679
TVA: FR07 499 824 670
SIRET: 499 824 670 000 24
All ordering procedures remain unchanged, and contacts remain the same.
About OriBase Pharma
OriBase Pharma is an international contract research organization (CRO) specialized in the design and chemistry synthesis of kinase inhibitors, and dedicated to accelerating drug discovery processes.
Our mission is to deliver safe, drug-like novel molecular entities for clients’ projects through the application of a unique technology platform & efficient discovery processes. Our commitment is to accomplish this with the highest quality & speed.
Our technologies are based on a unique combination of rational in silico drug design & medicinal chemistry services.